Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 444.00
+1.00 (0.23%)
Aug 13, 2025, 4:35 PM BST
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 470.46 million as of August 13, 2025. Its market cap has increased by 20.75% in one year.
Market Cap
470.46M
Enterprise Value
522.02M
Revenue
128.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
444.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 470.46M, an increase of 2,604.80%. That is a compound annual growth rate of 12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 470.46M | 5.74% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | 847.63M | 71.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.37B |
| GSK plc | 55.99B |
| Haleon | 31.89B |
| Smith & Nephew | 11.72B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| HUTCHMED (China) | 1.93B |